e-learning
resources
Amsterdam 2011
Tuesday, 27.09.2011
Novel mechanisms in lung injury
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Contribution of TGFβ1 and TIMP2 to clinical activity of asthma and COPD
N. Abolfath Zade Ghalejooghi, M. Ghanei, M. R. Nourani, A. Amini Harandi, A. A. Imani Fooladi (Tehran, Islamic Republic Of Iran)
Source:
Annual Congress 2011 - Novel mechanisms in lung injury
Session:
Novel mechanisms in lung injury
Session type:
Thematic Poster Session
Number:
3907
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
N. Abolfath Zade Ghalejooghi, M. Ghanei, M. R. Nourani, A. Amini Harandi, A. A. Imani Fooladi (Tehran, Islamic Republic Of Iran). Contribution of TGFβ1 and TIMP2 to clinical activity of asthma and COPD. Eur Respir J 2011; 38: Suppl. 55, 3907
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Related content which might interest you:
Sputum MMP-12 concentration and enzyme activity in COPD and asthma in relation to smoking status and disease severity
Source: Annual Congress 2010 - Induced sputum in relation: a fresh look on phenotyping and monitoring
Year: 2010
Role of matrix metalloproteinase in predicting of COPD stability
Source: International Congress 2015 – COPD: notable points
Year: 2015
Role of functional assessment in asthma and COPD
Source: ERS Skills course - Biomarkers and functional assessment of obstructive lung diseases
Year: 2017
The expression of MMP2, 9 and TIMP1 mRNA in bronchoalveolar cells of patients with chronic obstructive pulmonary disease (COPD) and bronchial asthma
Source: Annual Congress 2009 - New results in molecular pathology and functional genomics of non-neoplastic lung diseases
Year: 2009
Role of activated complement in COPD exacerbation recovery
Source: International Congress 2014 – Comorbidities
Year: 2014
Mechanisms in COPD compared with asthma
Source: Breathe 2008; 5: 134-144
Year: 2008
Induced sputum in asthma and COPD: meassuring type and inflammation activity
Source: Eur Respir J 2003; 22: Suppl. 45, 76s
Year: 2003
Pulmonary biomarkers in asthma and COPD
Source: Annual Congress 2007 - PG13 - Outcome measures of clinical trials for new drugs for respiratory disease
Year: 2007
Altered expression of glycosaminoglycans in the BAL of COPD patients with acute exacerbation
Source: Annual Congress 2013 –Translational studies in chronic lung diseases: from bedside to bench
Year: 2013
Frequency and severity of exacerbations reflect COPD severity, but not COPD phenotype as determined by quantitative CT
Source: International Congress 2014 – Markers
Year: 2014
Serum hyaluronidase-1 is increased in COPD exacerbations and is associated with COPD severity and outcomes
Source: International Congress 2018 – Disease exacerbations from a molecular point of view
Year: 2018
Role of inflammatory biomarkers in COPD
Source: International Congress 2016 – Systemic biomarkers
Year: 2016
JAK/STATs in asthma and COPD
Source: Annual Congress 2004 - Transcription factors in airway disease
Year: 2004
Biomarkers in COPD exacerbation, the role of adiponectin
Source: International Congress 2014 – Predictors
Year: 2014
Neutrophil CD 64 expression as a diagnostic marker of pneumonia in patients with acute COPD exacerbation
Source: International Congress 2014 – Markers
Year: 2014
Neutrophil elastase levels in sputum of patients with different airway diseases: COPD, bronchiectasis and asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 95s
Year: 2002
Can roflumilast improve clinical outcomes in moderate-to-severe chronic obstructive pulmonary disease? A meta-analysis
Source: International Congress 2016 – COPD diagnosis and management
Year: 2016
Frequency of COPD exacerbations and severity of COPD
Source: Annual Congress 2013 –Predictors and triggers of asthma and COPD exacerbations
Year: 2013
DPP10 protein expression is associated with the pathogenesis of asthma and COPD
Source: Eur Respir J 2005; 26: Suppl. 49, 231s
Year: 2005
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept